Mechanism of the Dual Activities of Human CYP17A1 and Binding to Anti-Prostate Cancer Drug Abiraterone Revealed by a Novel V366M Mutation Causing 17,20 Lyase Deficiency
The CYP17A1 gene regulates sex steroid biosynthesis in humans through 17α-hydroxylase/17,20 lyase activities and is a target of anti-prostate cancer drug abiraterone. In a 46, XY patient with female external genitalia, together with a loss of function mutation S441P, we identified a novel...
Saved in:
Main Authors: | Mónica Fernández-Cancio (Author), Núria Camats (Author), Christa E. Flück (Author), Adam Zalewski (Author), Bernhard Dick (Author), Brigitte M. Frey (Author), Raquel Monné (Author), Núria Torán (Author), Laura Audí (Author), Amit V. Pandey (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2018-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Two cases of 17α-hydroxylase/17,20-lyase deficiency caused by the CYP17A1 mutation
by: Hae In Lee, et al.
Published: (2021) -
Full-term live birth in a woman with 17α-hydroxylase and 17,20-lyase deficiency with assisted reproductive technology: a case report
by: Sisi Xi, et al.
Published: (2023) -
Endocrine profiles and cycle characteristics of infertile 17α-hydroxylase/17,20-lyase Deficiency Patients undergoing assisted Reproduction Treatment: a retrospective cohort study
by: Ping Pan, et al.
Published: (2023) -
Study of RNA interference inhibiting rat ovarian androgen biosynthesis by depressing 17alpha-hydroxylase/17, 20-lyase activity in vivo
by: Yang Xing, et al.
Published: (2009) -
Association Between CYP17A1, CYB5A Polymorphisms and Efficacy of Abiraterone Acetate/Prednisone Treatment in Castration-Resistant Prostate Cancer Patients
by: Wu X, et al.
Published: (2020)